Ginwa Enterprise (Group) Inc. (SHA:600080)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Industry	542.33M	584.81M	559.99M	559.99M	512.47M
Pharmaceutical Commerce	954.41K	820.00K	640.00K	640.00K	-
Hospitality Industry	-	190.00K	4.80M	4.80M	21.85M
Offset	-293.50K	-360.00K	-30.00K	-30.00K	-280.00K
Total	542.99M	585.46M	565.40M	565.40M	534.04M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	544.04M	585.46M	565.40M	579.37M	534.04M
Total	544.04M	585.46M	565.40M	579.37M	534.04M

Data Source: S&P Global Market Intelligence Last updated: Aug 21, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error